Status:
COMPLETED
Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
Paul J. Patton Trust
Conditions:
Lung Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to look at several genes that might determine how the body processes the drugs used to treat lung, colorectal and head and neck cancers. The goal of this examination is to...
Detailed Description
This study is to establish a pilot pharmacogenomic program in identifying genetic variation to predict the safety, toxicity and/or efficacy of drugs. DNA will be extracted from patients' peripheral bl...
Eligibility Criteria
Inclusion
- Lung, Colorectal and Head and Neck Cancer Patients that have received or plan to receive chemotherapy as part of their treatment
Exclusion
- Colorectal cancer patients that have never received or will not receive chemotherapy as part of their therapy
- Head and Neck cancer patients that have never received or will not receive chemotherapy as part of their treatment
- Patients with cancer types other than colorectal or head and neck
- Unable to give informed consent
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00442520
Start Date
February 1 2006
End Date
September 1 2008
Last Update
November 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160